TipRanks
HEROZ, Inc. (JP:4382)
:4382
Japanese Market
Want to see JP:4382 full AI Analyst Report?

HEROZ, Inc. (4382) AI Stock Analysis

1 Followers

Top Page

JP:4382

HEROZ, Inc.

(4382)

Select Model
Select Model
Select Model
Neutral 64 (OpenAI - Gpt-5.6Sol)
Rating:64Neutral
Price Target:
¥1,462.00
▲(70.60% Upside)
Action:Reiterated
Date:10/24/26
Overall score reflects improving but still volatile financial performance and a strong technical uptrend, partially offset by a high valuation (P/E 49.6) and the lack of dividend yield data.
Positive Factors
Revenue Growth
Strong multi-year revenue expansion indicates that HEROZ is increasing demand for its AI-related offerings and extending its commercial reach. Continued growth in 2026 supports the durability of the business model and provides a foundation for operating leverage if execution remains consistent.
Negative Factors
Profitability Volatility
The sharp swing in net margins shows that earnings power remains inconsistent despite the 2026 recovery. Volatile profitability makes future results more difficult to predict, increases execution risk, and could limit the company’s ability to sustain reinvestment through weaker operating periods.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Strong multi-year revenue expansion indicates that HEROZ is increasing demand for its AI-related offerings and extending its commercial reach. Continued growth in 2026 supports the durability of the business model and provides a foundation for operating leverage if execution remains consistent.
Read all positive factors

HEROZ, Inc. (4382) vs. iShares MSCI Japan ETF (EWJ)

HEROZ, Inc. Business Overview & Revenue Model

Company Description
HEROZ, Inc. engages in planning, developing, and operating of intellectual games for smartphones by using its artificial intelligence and machine learning technology in Japan and internationally. The company is involved in the development of vario...
How the Company Makes Money
HEROZ, Inc. primarily generates revenue by providing AI-related offerings to businesses. Key revenue streams include (1) fees from developing and delivering AI solutions (e.g., building, customizing, and implementing AI models/systems for client u...

HEROZ, Inc. Financial Statement Overview

Summary
Financials show a constructive turnaround: strong multi-year revenue growth and a return to positive net income in 2026, with positive operating cash flow and free cash flow. However, profitability has been volatile (large margin swings from 2024–2026), and leverage is higher than in 2021–2022, increasing sensitivity if earnings weaken.
Income Statement
62
Positive
Balance Sheet
66
Positive
Cash Flow
59
Neutral
BreakdownTTMApr 2026Apr 2025Apr 2024Apr 2023Apr 2022
Income Statement
Total Revenue6.55B6.42B5.93B4.84B2.98B1.48B
Gross Profit3.08B2.92B2.69B2.39B1.35B553.36M
EBITDA968.03M1.17B566.25M-343.40M-168.66M240.52M
Net Income420.20M376.03M-177.71M-1.13B-574.33M49.40M
Balance Sheet
Total Assets8.44B8.50B8.19B7.69B8.67B6.66B
Cash, Cash Equivalents and Short-Term Investments2.63B1.95B3.15B2.74B3.80B3.66B
Total Debt1.54B1.65B2.05B1.40B1.50B0.00
Total Liabilities2.48B2.64B2.99B2.55B2.59B219.21M
Stockholders Equity5.83B5.06B4.64B4.79B5.87B6.44B
Cash Flow
Free Cash Flow0.00511.10M132.13M316.48M460.41M194.52M
Operating Cash Flow0.00592.83M219.03M464.00M483.38M198.15M
Investing Cash Flow0.0033.93M-479.27M-1.21B-144.47M-2.09B
Financing Cash Flow0.00-405.56M664.63M-306.18M-200.78M1.00K

HEROZ, Inc. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price857.00
Price Trends
50DMA
949.46
Positive
100DMA
836.09
Positive
200DMA
832.06
Positive
Market Momentum
MACD
173.69
Negative
RSI
56.05
Neutral
STOCH
39.45
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4382, the sentiment is Positive. The current price of 857 is below the 20-day moving average (MA) of 1206.25, below the 50-day MA of 949.46, and above the 200-day MA of 832.06, indicating a bullish trend. The MACD of 173.69 indicates Negative momentum. The RSI at 56.05 is Neutral, neither overbought nor oversold. The STOCH value of 39.45 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4382.

HEROZ, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
¥13.51B35.11――15.44%163.64%
69
Neutral
¥16.90B7.39―0.98%7.11%146.94%
64
Neutral
¥23.87B48.89――8.50%―
63
Neutral
¥12.86B51.17――34.57%80.99%
60
Neutral
¥4.34B12.60――24.15%252.38%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
43
Neutral
¥13.30B-455.94――75.12%97.01%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4382
HEROZ, Inc.
1,337.00
301.00
29.05%
JP:3853
Asteria Corporation
1,007.00
-627.59
-38.39%
JP:4425
Kudan, Inc.
1,174.00
176.00
17.64%
JP:4476
AI CROSS Inc
1,075.00
-723.00
-40.21%
JP:5572
Ridge-i Inc.
3,110.00
513.00
19.75%
JP:5586
Laboro.AI, Inc.
805.00
-121.00
-13.07%

HEROZ, Inc. Corporate Events

HEROZ Completes Issuance of Restricted Stock Compensation Shares
Sep 24, 2026
HEROZ, Inc. has completed payment procedures for the issuance of 67,395 new common shares as restricted stock compensation, following a board resolution made on August 20, 2026. The shares, issued at 739 yen each for a total of 49,804,905 yen, for...
HEROZ Issues Translated Q1 FY2027 Financial Presentation
Sep 14, 2026
HEROZ, Inc. released presentation materials for its fiscal year ending April 2027 first-quarter financial results dated September 11, 2026, providing investors with an overview of its recent performance. The document, presented as an excerpted Eng...
HEROZ Posts Strong Q1 Earnings and Affirms Zero-Dividend Stance
Sep 11, 2026
HEROZ, Inc. reported consolidated net sales of ¥1,643 million for the three months ended July 31, 2026, an 8.5% year-on-year increase, with operating profit before goodwill amortization rising 40.8% to ¥223 million. Profit attributable t...
HEROZ to Issue Restricted Stock as Equity Compensation to Directors and Employees
Aug 21, 2026
HEROZ, Inc. has approved the issuance of 67,395 new shares of common stock as restricted stock compensation to directors, executive officers, and employees of the company and its subsidiary, with a total value of 49,804,905 yen at an issue price o...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 24, 2026